The genus Euphorbia is large and chemically diverse, notably rich in triterpenoids and diterpenoids with reported biological activities. Euphorbia systyloides Pax. (Euphorbiaceae) is native to tropical Africa. Traditional use of its leaf decoction includes treatment for tapeworm infections. Prior to this study, the chemistry of E. systyloides had not been investigated in detail.
The primary aims were to isolate and structurally characterize terpenoid constituents from E. systyloides and to evaluate their biological activity against the protozoan parasite Trypanosoma cruzi and against tumor cells. The researchers also sought to assess cytotoxicity toward representative human immune cells and to investigate potential immunomodulatory effects in infected macrophages.
Plant material underwent multistep chromatographic separation to yield terpenoid compounds. Structural elucidation relied on high-resolution mass spectrometry (HRMS) and one- and two-dimensional nuclear magnetic resonance (1D/2D NMR) spectroscopy. In total, twelve triterpenes were isolated and identified: six previously undescribed euphane and tirucallane triterpenes and six known triterpenes. The abstract reports the discovery of these new natural products but does not provide the full structural tables or spectral data within the abstract text; such details would be expected in the full article.
Anti-Trypanosoma cruzi activity was evaluated using multiple in vitro assays. Epimastigote viability was measured by an XTT assay. Cellular infection models assessed host cell infection and intracellular amastigote replication. According to the abstract, none of the isolated triterpenes demonstrated selective activity against T. cruzi in the assays performed. One compound, kansenonol, produced an unexpected increase in amastigote replication in host cells during a trypomastigote infection assay; the authors link this to effects on host macrophage function rather than direct antiparasitic action.
Cytotoxicity was analyzed using the MTT assay in two human leukemia cell lines (HL60 and U937) and in peripheral blood mononuclear cells (PBMCs). While most triterpenes did not show selective antiparasitic activity, the study identified an ergostane triterpene that displayed nanomolar cytotoxic potency against HL60 and U937 cells. This ergostane compound also exhibited moderate toxicity toward PBMCs, indicating some level of nonselective cytotoxicity in primary human immune cells as reported in the abstract.
To explore host-directed effects suggested by the increased amastigote replication with kansenonol, the authors assessed cytokine production in infected macrophages. Measurement of TNF-α and IL-10 by ELISA was used to evaluate immunomodulatory activity. The abstract reports that kansenonol exerted significant immunomodulatory effects in vitro, consistent with the observed enhancement of intracellular parasite replication. Exact cytokine level changes and assay conditions are not detailed in the abstract and were not reported in the source abstract.
Twelve triterpenes were isolated from E. systyloides: six new euphane/tirucallane derivatives and six known triterpenes.
No compound demonstrated selective antiparasitic activity against Trypanosoma cruzi in epimastigote or cellular assays reported in the abstract.
One ergostane triterpene was potently cytotoxic to leukemia cell lines (HL60 and U937) at nanomolar concentrations and showed moderate toxicity to PBMCs.
Kansenonol unexpectedly increased amastigote replication in host cells in a trypomastigote infection assay, an effect attributed to macrophage immunomodulation supported by ELISA measurements of TNF-α and IL-10.
The findings reframe the biological profile of triterpenoids from E. systyloides: rather than serving as selective antiparasitic agents against T. cruzi, these molecules primarily exhibit cytotoxic and immunomodulatory activities in vitro. The potent nanomolar activity of the isolated ergostane triterpene against leukemia cell lines highlights this scaffold as an underexplored lead for antileukemic drug discovery. At the same time, the immunomodulatory action observed for kansenonol cautions that host-directed effects can increase intracellular parasite replication in cellular infection models, complicating interpretation of antiparasitic assays.
The abstract does not give full quantitative datasets (for example, specific IC50 values for each compound across all assays) or detailed experimental conditions; those data were not reported in the abstract and would need to be consulted in the full text for deeper evaluation.
In summary, triterpenoids isolated from E. systyloides were characterized and profiled for antiparasitic, cytotoxic, and immunomodulatory activities. The principal conclusions reported in the abstract are:
The isolated triterpenes do not show selective activity against Trypanosoma cruzi under the tested conditions.
An ergostane triterpene exhibits promising antileukemic cytotoxicity in vitro and may be a scaffold for further drug discovery.
Kansenonol demonstrates in vitro immunomodulatory effects that correlated with an increase in intracellular amastigote replication in a host cell infection assay.
Limitations noted from the abstract: specific numerical assay results, detailed experimental parameters, and full structural data are not provided in the abstract and therefore were not available from the source abstract text. Further reading of the full article is required to obtain complete methods, full spectroscopic characterization, and comprehensive activity data.
Keywords reported in the source include: Euphorbia systyloides; Trypanosoma cruzi; antileukemic; immunomodulatory effect; triterpenes.